WNT5A and ovarian carcinoma: However, more lines of study suggested that activation of noncanonical Wnt signaling, such as the Wnt5a-mediated signaling, was aberrantly enhanced in many epithelial cancers, including the lung cancer [15], breast cancer [16], ovarian cancer [17, 18], and gastric cancer [19].